Xiaojin Ning
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xiaojin Ning has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Aiguo Shen
Cancer Research Center Nantong, Affiliated Tumor Hospital of Nantong University, Nantong, China
1 shared publication - Chi Sun
Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong, 226001, China
1 shared publication - Dongmei Zhang
Medical Research Center, Affiliated Hospital 2 of Nantong University, Nantong, China
1 shared publication - Hongmei Wang
Department of Neurology, Affiliated Hospital of Nantong University, Nantong, 226001, China
1 shared publication - Jianhong Shen
Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, China
1 shared publication - Kaifu Ke
Affiliated Hospital of Nantong University
1 shared publication
Latest Publications
- 17 June 2016
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 37 (3) , 527-536
The O-GlcNAc Modification of CDK5 Involved in Neuronal Apoptosis Following In Vitro Intracerebral Hemorrhage
Contrary to cell cycle-associated cyclin-dependent kinases, CDK5 is best known for its regulation of signaling processes in regulating mammalian CNS development. Studies of CDK5 have focused on its phosphorylation, although the diversity of CDK5 functions in the brain suggests additional forms of regulation. Here we expanded on the functional roles of CDK5 glycosylation in neurons. We showed that CDK5 was dynamically modified with O-GlcNAc in response to neuronal activity and that glycosylation represses CDK5-dependent apoptosis by impairing its association with p53 pathway. Blocking glycosylation of CDK5 alters cellular function and increases neuronal apoptosis in the cell model of the ICH. Our findings demonstrated a new role for O-glycosylation in neuronal apoptosis and provided a mechanistic understanding of how glycosylation contributes to critical neuronal functions. Moreover, we identified a previously unknown mechanism for the regulation of activity-dependent gene expression, neural development, and apoptosis.
- 17 June 2016
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 37 (3) , 527-536
The O-GlcNAc Modification of CDK5 Involved in Neuronal Apoptosis Following In Vitro Intracerebral Hemorrhage
Contrary to cell cycle-associated cyclin-dependent kinases, CDK5 is best known for its regulation of signaling processes in regulating mammalian CNS development. Studies of CDK5 have focused on its phosphorylation, although the diversity of CDK5 functions in the brain suggests additional forms of regulation. Here we expanded on the functional roles of CDK5 glycosylation in neurons. We showed that CDK5 was dynamically modified with O-GlcNAc in response to neuronal activity and that glycosylation represses CDK5-dependent apoptosis by impairing its association with p53 pathway. Blocking glycosylation of CDK5 alters cellular function and increases neuronal apoptosis in the cell model of the ICH. Our findings demonstrated a new role for O-glycosylation in neuronal apoptosis and provided a mechanistic understanding of how glycosylation contributes to critical neuronal functions. Moreover, we identified a previously unknown mechanism for the regulation of activity-dependent gene expression, neural development, and apoptosis.